The Company has secured nearly $20 million in gross proceeds in 2025 ensuring complete funding for its pivotal CLARITY trialCLARITY is a ...

Northwestern Medicine is a global leader in clinical trial research, including spineCLARITY is a randomized study designed to demonstrate ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company with a market capitalization of ...

Chicago-based Northwestern Medicine will be the first site for Clarion's Clarity trial for spine surgery, according to a Feb. 6 news release.

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at where Aclarion, Inc. (NASDAQ:ACON) stands against the other AI stocks ...

Aclarion stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its ...

Renowned spine specialist, Dr. Sigurd Berven, will present Aclarion's flagship platform, NOCISCAN, highlighting its innovative, evidence-supported capabilities. “Aclarion is pleased to have ...

Aclarion, Inc. is set to showcase its advanced platform, NOCISCAN, at the Selby Spine Conference, presented by Dr. Sigurd Berven. NOCISCAN combines MR Spectroscopy and augmented intelligence to ...

“We intend to lead a positive diagnostic transformation in spine care through clinical and economic evidence that proves the promising value of Nociscan. The building blocks we have executed ...

Aclarion's NOCISCAN aims to set a new standard for diagnosing the source of discogenic pain, a significant global health issue affecting millions. The platform is designed to help physicians ...